[HTML] springer.comFull View

[HTML][HTML] ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo

K Yan, J Zheng, MA Kluth, L Li, C Ganss, B Yard… - Stem Cell Research & …, 2023 - Springer
Background Hypoxia in ischemic disease impairs Ca2+ homeostasis and may promote
angiogenesis. The therapeutic efficacy of mesenchymal stromal cells (MSCs) in peripheral …
相关文章

ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo

K Yan, J Zheng, MA Kluth, L Li, C Ganss, B Yard… - 2023 - agris.fao.org
Background Hypoxia in ischemic disease impairs Ca2+ homeostasis and may promote
angiogenesis. The therapeutic efficacy of mesenchymal stromal cells (MSCs) in peripheral …

ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo.

K Yan, J Zheng, MA Kluth, L Li, C Ganss… - Stem Cell Research & …, 2023 - europepmc.org
Background Hypoxia in ischemic disease impairs Ca 2+ homeostasis and may promote
angiogenesis. The therapeutic efficacy of mesenchymal stromal cells (MSCs) in peripheral …
[HTML] nih.gov

[HTML][HTML] ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo

K Yan, J Zheng, MA Kluth, L Li, C Ganss… - Stem Cell Research & …, 2023 - ncbi.nlm.nih.gov
Background Hypoxia in ischemic disease impairs Ca 2+ homeostasis and may promote
angiogenesis. The therapeutic efficacy of mesenchymal stromal cells (MSCs) in peripheral …

[引用][C] ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo

Y Kaixuan, Z Jiaxing, K Andreas, L Lin… - Stem Cell Research & …, 2023 - jglobal.jst.go.jp
ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+
homeostasis in vitro and in vivo | Article Information | J-GLOBAL Art J-GLOBAL ID:202402268868640564 …

ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo.

K Yan, J Zheng, MA Kluth, L Li… - Stem Cell Research …, 2023 - search.ebscohost.com
Background: Hypoxia in ischemic disease impairs Ca< sup> 2+ homeostasis and may
promote angiogenesis. The therapeutic efficacy of mesenchymal stromal cells (MSCs) in …

ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo

K Yan, J Zheng, MA Kluth, L Li, C Ganss… - Stem Cell Research …, 2023 - search.proquest.com
Background Hypoxia in ischemic disease impairs Ca 2+ homeostasis and may promote
angiogenesis. The therapeutic efficacy of mesenchymal stromal cells (MSCs) in peripheral …
[HTML] biomedcentral.com

[HTML][HTML] ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo

K Yan, J Zheng, MA Kluth, L Li… - … Cell Research & …, 2023 - stemcellres.biomedcentral.com
Hypoxia in ischemic disease impairs Ca2+ homeostasis and may promote angiogenesis.
The therapeutic efficacy of mesenchymal stromal cells (MSCs) in peripheral arterial …

ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo

K Yan, J Zheng, MA Kluth, L Li, C Ganss, B Yard… - 2023 - ro.ecu.edu.au
Background: Hypoxia in ischemic disease impairs Ca 2+ homeostasis and may promote
angiogenesis. The therapeutic efficacy of mesenchymal stromal cells (MSCs) in peripheral …

ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo

K Yan, J Zheng, MA Kluth, L Li… - Stem cell research …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Hypoxia in ischemic disease impairs Ca 2+ homeostasis and may promote
angiogenesis. The therapeutic efficacy of mesenchymal stromal cells (MSCs) in peripheral …